典型文献
Common traditional Chinese medicine therapies for diarrhea-predominant irritable bowel syndrome:An overview of systematic reviews
文献摘要:
Objective:To critically evaluate and summarize the methodological quality of systematic reviews(SRs)and present objective and important outcomes on the effectiveness of traditional Chinese medicine(TCM)therapies,including Chinese herbal medicine(CHM),acupuncture,and moxibustion,for diarrhea-predominant irritable bowel syndrome(IBS-D).Methods:We conducted a comprehensive literature search for SRs in 7 databases until April 16,2022.Two reviewers independently extracted data and assessed the methodological quality of the reviews according to the Assessing the Methodological Quality of Systematic Reviews 2(AMSTAR-2),the Risk of Bias in Systematic reviews(ROBIS)tool,and the Preferred Reporting Item for Systematic Review and Meta-analysis(PRISMA)statement.The Grading of Recommendations,Assessment,Development,and Evaluation(GRADE)was used to rate the quality of evidence.Results:IBS-D patients included in 12 reviews were diagnosed in accordance with the Rome criteria,9 reviews focused on CHM,2 articles observed moxibustion and heat-sensitive moxibustion,1 article studied acupuncture and CHM.The outcomes of the SRs were the effectiveness rate,the total effectiveness rate,global symptom improvement,and adverse effects.Based on AMSTAR-2,which measures the quality of methodology,all of the included studies were of low or critically low quality.According to the ROBIS tool,10 SRs(83.33%)had a high risk of bias.With the PRISMA checklist,only 3 SRs reached over 90%compliance.Based on GRADE,most evidence was of low quality,and there was a moderate quality of evidence that the effectiveness rate of modified-Tongxie Yaofang was superior to Western medicine in the treatment of IBS-D.Conclusion:Given the suboptimal reporting and methodological quality of existing SRs,more studies are needed to clarify whether TCM therapies are more effective or safe than pharmacological medicine.Future studies should combine evidence-based medicine with TCM research according to the charac-teristics of TCM.
文献关键词:
中图分类号:
作者姓名:
Jun Zhao;Xia Li;Xiaowei Chen;Hui Zheng;Kun Ye;Yunzhou Shi;Xin Xie;Jianfang Wang;Min Chen;Zhigang Li
作者机构:
School of Acupuncture,Moxibustion and Tuina,Beijing University of Chinese Medicine,Beijing,102488,China;Department of Spleen,Stomach,Liver and Gallbladder Diseases,Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,100078,China;The Third Hospital/Acupuncture and Tuina School,Chengdu University of Traditional Chinese Medicine,Chengdu,610075,China;Anorectal Disease Department,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu,610072,China
文献出处:
引用格式:
[1]Jun Zhao;Xia Li;Xiaowei Chen;Hui Zheng;Kun Ye;Yunzhou Shi;Xin Xie;Jianfang Wang;Min Chen;Zhigang Li-.Common traditional Chinese medicine therapies for diarrhea-predominant irritable bowel syndrome:An overview of systematic reviews)[J].中医科学杂志(英文),2022(03):330-339
A类:
Tongxie,Yaofang
B类:
Common,traditional,Chinese,medicine,therapies,diarrhea,predominant,irritable,bowel,syndrome,An,overview,systematic,reviews,Objective,critically,evaluate,summarize,methodological,quality,SRs,present,objective,important,outcomes,effectiveness,TCM,including,herbal,CHM,acupuncture,moxibustion,IBS,Methods,conducted,comprehensive,literature,databases,until,April,Two,reviewers,independently,extracted,assessed,according,Assessing,Methodological,Quality,Systematic,Reviews,AMSTAR,Risk,Bias,ROBIS,tool,Preferred,Reporting,Item,analysis,PRISMA,statement,Grading,Recommendations,Assessment,Development,Evaluation,GRADE,was,evidence,Results,patients,included,were,diagnosed,accordance,Rome,criteria,focused,articles,observed,heat,sensitive,studied,total,global,symptom,improvement,adverse,effects,Based,which,measures,methodology,studies,low,According,had,high,risk,bias,With,checklist,only,reached,compliance,most,there,moderate,that,modified,superior,treatment,Conclusion,Given,suboptimal,reporting,existing,more,are,needed,clarify,whether,safe,than,pharmacological,Future,should,combine,research,charac,teristics
AB值:
0.520305
相似文献
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。